about
siRNA Versus miRNA as Therapeutics for Gene SilencingDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideIntranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptomsA Novel, Stable, Estradiol-Stimulating, Osteogenic Yam Protein with Potential for the Treatment of Menopausal Syndrome.Pulmonary delivery of therapeutic siRNA.Biomedical applications of amino acid-modified chitosans: a review.Oral transmucosal drug delivery for pediatric use.Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis.Oleanolic Acid Loaded PEGylated PLA and PLGA Nanoparticles with Enhanced Cytotoxic Activity against Cancer Cells.Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.Manipulating the pH response of 2,3-diaminopropionic acid rich peptides to mediate highly effective gene silencing with low-toxicityFormulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.Steroidogenic effect of Erxian decoction for relieving menopause via the p-Akt/PKB pathway in vitro and in vivo.DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.The involvement of microtubules and actin filaments in the intracellular transport of non-viral gene delivery system.Phosphorylcholine-polycation diblock copolymers as synthetic vectors for gene delivery.Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.Incorporation of a Nuclear Localization Signal in pH Responsive LAH4-L1 Peptide Enhances Transfection and Nuclear Uptake of Plasmid DNA.Structural contributions to the intracellular targeting strategies of antimicrobial peptides.Erratum: A Novel, Stable, Estradiol-Stimulating, Osteogenic Yam Protein with Potential for the Treatment of Menopausal Syndrome.Structural study of DNA condensation induced by novel phosphorylcholine-based copolymers for gene delivery and relevance to DNA protection.From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis.Chemical–physical properties and cytotoxicity of N -decanoyl amino acid-based surfactants: Effect of polar headsPorous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung depositionUsing two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalationSynthesis, Structure⁻Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability EnhancersEffective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptideComparative Study of Diethylaminoethyl-Chitosan and Methylglycol-Chitosan as Potential Non-Viral Vectors for Gene Therapy
P50
Q26786876-096526E4-FC5A-4F4D-B0A1-DCA2E81B9F36Q28067306-03D19637-8350-4AE2-A40C-2186414229D3Q34309830-A1A7E54D-1B9E-49B4-8A4F-F2DFB0EAE781Q35863748-FF145AA1-59AB-493D-A42C-032D9F849D17Q37502138-42DF84A8-69F5-4728-9076-58BF2981ED48Q37847687-D454F205-5DB5-46D3-8309-DFADD45EFC91Q38028091-A7147D31-5DAF-4DB6-82D5-C3E092559901Q38133723-1DC1130C-23A2-4EB0-B6AF-3A7B75D69BFEQ38816017-48A67654-7965-436C-9F83-748396D786F0Q38886207-C49877B6-10BA-4A98-AE05-415CE91334F0Q38918762-0E4FB386-FB15-449F-98B5-CA8C8BB7CB04Q39075571-6C4FD8F9-2C5A-47AE-B43F-2C131A03AA5DQ39148199-3940D80D-299E-46E1-9C60-F4E5A9CC9980Q39166876-F001123B-4238-4779-AFD5-729FE128F492Q39182355-344327D5-9AE0-4BD3-B730-6C3EEF6DDF2AQ39301392-5D651019-6ED0-4DF3-8397-811E788C17F8Q39433772-1363570C-D20C-42F4-AD49-B8B0D749214DQ39720959-24BC6AE4-8F23-47CB-A0C9-EB8B6BBCAEECQ40491874-978FE6C9-513B-4F9C-B91C-AE5D40E8A167Q40762047-99C04BC9-C97F-4210-A5C9-A19814ECD07FQ42050493-D0B9A241-E4E9-474E-9873-FE1CDEDA8C5AQ42174231-CEC43215-3A10-4F96-827C-2CE4F907DB5DQ43124166-6D9DE5B0-EE8B-4894-AAF1-9848387DA152Q45882388-E42008CD-AE81-4594-B8D8-F45892B0D096Q47420490-1873D7D9-F221-4C0F-A35E-546210254A92Q47829347-6165AE73-8284-4265-9928-10C184708AB7Q48271330-1E5E87B1-6E9C-4F11-959E-0ACD7E983598Q57539423-F1E76A1B-59D6-4305-9B9F-2C6F55667C02Q64132098-FFFB344C-CB98-44E4-9C9E-F2DF670CBBBCQ64132110-FD122E45-74B5-4399-AB4D-4C185954FB56Q89411696-7B26D6FF-F5E8-4CBE-A622-7662B13EDB4DQ90817458-31EBC97C-3C2C-40FA-BB7C-DB9171D0E08BQ92979323-7005E212-CCDE-4256-8881-BBC61B60A16A
P50
description
researcher ORCID ID = 0000-0003-2997-010X
@en
wetenschapper
@nl
name
Jenny K.W. Lam
@ast
Jenny K.W. Lam
@en
Jenny K.W. Lam
@es
Jenny K.W. Lam
@nl
type
label
Jenny K.W. Lam
@ast
Jenny K.W. Lam
@en
Jenny K.W. Lam
@es
Jenny K.W. Lam
@nl
prefLabel
Jenny K.W. Lam
@ast
Jenny K.W. Lam
@en
Jenny K.W. Lam
@es
Jenny K.W. Lam
@nl
P106
P1153
8404243000
P31
P496
0000-0003-2997-010X